Mesa Laboratories (NASDAQ:MLAB – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, February 4th. Analysts expect Mesa Laboratories to post earnings of $1.41 per share and revenue of $58.83 million for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Mesa Laboratories (NASDAQ:MLAB – Get Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $1.81 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.14). The firm had revenue of $57.83 million for the quarter, compared to analyst estimates of $58.60 million. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%. On average, analysts expect Mesa Laboratories to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Mesa Laboratories Price Performance
MLAB opened at $137.69 on Friday. Mesa Laboratories has a twelve month low of $83.68 and a twelve month high of $149.50. The firm has a market cap of $747.66 million, a price-to-earnings ratio of -3.02 and a beta of 0.82. The company has a current ratio of 0.70, a quick ratio of 0.51 and a debt-to-equity ratio of 0.65. The company has a fifty day simple moving average of $132.44 and a 200 day simple moving average of $125.09.
Mesa Laboratories Announces Dividend
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, November 13th.
Get Our Latest Analysis on MLAB
About Mesa Laboratories
Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.
Featured Stories
- Five stocks we like better than Mesa Laboratories
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Profitably Trade Stocks at 52-Week Highs
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How to Buy Cheap Stocks Step by Step
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.